Clinical Trials for Intermediate- and High-risk Myelofibrosis (MF) Patients With Splenomegaly

Find clinical trials for intermediate- and high-risk myelofibrosis (mf) patients with splenomegaly. Discover research opportunities and treatment options in your area.

1 Active Trial Found

Showing 1 trial on this page

Page 1 of 1

A Study to Evaluate Safety , Efficacy and Pharmacokinetics of WJ01024 Tablets Combined With Ruxolitinib in Patients With Myelofibrosis

NCT ID: NCT06909136

This clinical trial is investigating a new treatment option for patients with myelofibrosis, a type of blood cancer that can cause symptoms like an enlarged spleen. Researchers want to learn about ...

Not yet recruiting

Phase: PHASE1 Type: interventional Locations: Zhengzhou, Zhengzhou, China

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions